This section considers submissions that demonstrate advances in urological minimally invasive surgical procedures, including robotic, laparoscopic and endourologic surgery. Research papers which report new technologies and their application in clinical practice are also considered.
Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer
The purpose of this study was to assess the efficacy of Bacillus Calmette-Guerin (BCG) therapy after a second transurethral resection (TUR) in new onset high-grade T1 bladder cancer.
Citation: BMC Urology 2016 16:8